Identification and management of tuberculosis

Area of Science:

• Public Health
• Infectious Diseases
• Medical Microbiology

Background:

• Tuberculosis (TB) resurgence in the 1990s is controlled, but high-risk populations persist.
• Homeless individuals, recent immigrants, and HIV-infected persons face elevated TB risks.
• Purified protein derivative (PPD) testing is crucial for early detection in these vulnerable groups.

Purpose of the Study:

• To outline current recommendations for tuberculosis diagnosis and treatment.
• To address specific challenges in managing TB in high-risk populations, including HIV-coinfected patients.
• To emphasize strategies for improving patient compliance and preventing drug resistance.

Main Methods:

• Review of current guidelines for tuberculosis management.
• Discussion of pharmacotherapy for latent and active tuberculosis.
• Consideration of drug interactions and alternative regimens for HIV-infected patients on antiretroviral therapy.
• Emphasis on directly observed therapy (DOT) for enhanced compliance.

Main Results:

• Latent TB is typically treated with nine months of isoniazid.
• Active TB requires a four-drug initial regimen for at least two months.
• Alternative regimens avoiding rifampin are recommended for HIV patients on protease inhibitors or NNRTIs.
• Directly observed therapy is recommended to maximize compliance and minimize resistance.

Conclusions:

• Targeted PPD testing is essential for high-risk populations.
• Treatment regimens must be individualized based on disease status and patient factors, including HIV coinfection.
• Directly observed therapy is a key strategy for successful tuberculosis treatment and prevention of drug resistance.